When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
TAK - Takeda's TAK-925 shows encouraging action in early-stage narcolepsy study
Takeda Pharmaceutical Company Limited American Depositary Shares
Results from a Phase 1 proof-of-concept study evaluating Takeda Pharmaceutical's (NYSE:TAK) TAK-925, a selective orexin type-2 receptor (OX2R) agonist, in patients with narcolepsy type 1 (NT1) showed a treatment effect. The data were presented at the World Sleep Congress in Vancouver.
More news on: Takeda Pharmaceutical Company Limited, Jazz Pharmaceuticals plc, Healthcare stocks news,